Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lieberman

Showing results (621-630 of 1,485) with videos related to

Pageof 149
Sort By:
Schizophrenia Bulletin|January 1, 1991
Update on the clinical efficacy and side effects of clozapineA Safferman, J A Lieberman, J M Kane, et al.
Developmental Neuroscience|April 17, 2003
Developmental effects of prenatal cocaine exposure on 5-HT1A receptors in male and female rat offspringJosephine M Johns, Deborah A Lubin, Jeffrey A Lieberman, et al.
Biological Psychiatry|October 18, 2000
Cortical bcl-2 protein expression and apoptotic regulation in schizophreniaL F Jarskog, J H Gilmore, E S Selinger, et al.
The Journal of Nervous and Mental Disease|October 3, 2001
Seasonal admission patterns in first episode psychosis, chronic schizophrenia, and nonschizophrenic psychosesR D Strous, S Pollack, D Robinson, et al.
Psychopharmacology|April 6, 2006
Neonatal neurosteroid administration results in development-specific alterations in prepulse inhibition and locomotor activity: neurosteroids alter prepulse inhibition and locomotor activitySamantha S Gizerian, Sheryl S Moy, Jeffrey A Lieberman, et al.
Nature Reviews. Drug Discovery|March 7, 2006
Clinical trials for antipsychotic drugs: design conventions, dilemmas and innovationsT Scott Stroup, Wayne M Alves, Robert M Hamer, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 24, 2005
Apoptotic mechanisms in the pathophysiology of schizophreniaL Fredrik Jarskog, Leisa A Glantz, John H Gilmore, et al.
Psychopharmacology|December 20, 2005
Effects of haloperidol, clozapine, and quetiapine on sensorimotor gating in a genetic model of reduced NMDA receptor functionGary E Duncan, Sheryl S Moy, Jeffery A Lieberman, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 20, 2005
Prevalence of polyps greater than 9 mm in a consortium of diverse clinical practice settings in the United StatesDavid A Lieberman, Jennifer Holub, Glenn Eisen, et al.
European Neurology|January 1, 1990
Randomized double-blind cross-over study of Sinemet-controlled release (CR4 50/200) versus Sinemet 25/100 in Parkinson's diseaseA Lieberman, G Gopinathan, E Miller, et al.
Pageof 149

Showing results (621-630 of 1,485) with videos related to

Sort By:
Pageof 149
Schizophrenia Bulletin|January 1, 1991
Update on the clinical efficacy and side effects of clozapineA Safferman, J A Lieberman, J M Kane, et al.
Developmental Neuroscience|April 17, 2003
Developmental effects of prenatal cocaine exposure on 5-HT1A receptors in male and female rat offspringJosephine M Johns, Deborah A Lubin, Jeffrey A Lieberman, et al.
Biological Psychiatry|October 18, 2000
Cortical bcl-2 protein expression and apoptotic regulation in schizophreniaL F Jarskog, J H Gilmore, E S Selinger, et al.
The Journal of Nervous and Mental Disease|October 3, 2001
Seasonal admission patterns in first episode psychosis, chronic schizophrenia, and nonschizophrenic psychosesR D Strous, S Pollack, D Robinson, et al.
Psychopharmacology|April 6, 2006
Neonatal neurosteroid administration results in development-specific alterations in prepulse inhibition and locomotor activity: neurosteroids alter prepulse inhibition and locomotor activitySamantha S Gizerian, Sheryl S Moy, Jeffrey A Lieberman, et al.
Nature Reviews. Drug Discovery|March 7, 2006
Clinical trials for antipsychotic drugs: design conventions, dilemmas and innovationsT Scott Stroup, Wayne M Alves, Robert M Hamer, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 24, 2005
Apoptotic mechanisms in the pathophysiology of schizophreniaL Fredrik Jarskog, Leisa A Glantz, John H Gilmore, et al.
Psychopharmacology|December 20, 2005
Effects of haloperidol, clozapine, and quetiapine on sensorimotor gating in a genetic model of reduced NMDA receptor functionGary E Duncan, Sheryl S Moy, Jeffery A Lieberman, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 20, 2005
Prevalence of polyps greater than 9 mm in a consortium of diverse clinical practice settings in the United StatesDavid A Lieberman, Jennifer Holub, Glenn Eisen, et al.
European Neurology|January 1, 1990
Randomized double-blind cross-over study of Sinemet-controlled release (CR4 50/200) versus Sinemet 25/100 in Parkinson's diseaseA Lieberman, G Gopinathan, E Miller, et al.
Pageof 149